OOTR-N016 Trial Results to be Presented at SABCS 2022

The results of the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) are going to be presented at the 2022 San Antonio Breast Cancer Symposium (SABCS) under the following title:

(P5-09-01) Neoadjuvant hormonal therapy plus palbociclib versus hormonal therapy plus placebo in women with operable, hormone sensitive and HER2-negative primary breast cancer

[link will be provided when the SABCS meeting resources are made available to the public]

Based on a separate protocol, translational research is ongoing to analyze the molecular changes by treatments.